LYRM7: A Non-Code RNA Molecule with Potential Drug Targets (G90624)

Target Name: LYRM7

NCBI ID: G90624

LYRM7: A Non-Code RNA Molecule with Potential Drug Targets

LYRM7 (lysine-rich motif-containing 7), also known as LYRM7, is a non-coding RNA molecule that has been identified in various cellular processes. It is composed of 7 conserved non-coding RNAs that are arranged in a specific order. LYRM7 is highly expressed in various tissues and has been implicated in various cellular processes, including cell signaling, stem cell biology, and development.

Drug Target Potential

The potential drug targets for LYRM7 are numerous and varied. Its unique structure and various functions make it an attractive target for researchers to explore. One of the primary drug targets for LYRM7 is its role in cell signaling. LYRM7 has been shown to play a critical role in various signaling pathways, including the TGF-β pathway and the Wnt pathway.

Additionally, LYRM7 has been linked to various diseases, including cancer, neurodegenerative diseases, and developmental disorders. Its involvement in these diseases makes it an attractive target for small molecules that can modulate its function and have therapeutic effects.

Another potential drug target for LYRM7 is its role in stem cell biology. LYRM7 has been shown to be involved in the regulation of stem cell proliferation and differentiation. It has been shown to play a critical role in the self-renewal ability of stem cells and has been implicated in the development of various diseases, including cancer.

LYRM7 has also been shown to be involved in various cellular processes that are important for human development and survival. For example, LYRM7 has been shown to play a critical role in the development and maintenance of the nervous system, and its dysfunction has been linked to various neurological disorders, including Alzheimer's disease and Parkinson's disease.

Biomarker Potential

The potential use of LYRM7 as a biomarker for various diseases makes it an attractive target for researchers to explore. LYRM7 has been shown to be involved in the regulation of cellular processes that are important for disease progression, including cell signaling, stem cell biology, and neurodegenerative diseases.

For example, LYRM7 has been shown to play a critical role in the regulation of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. Its dysfunction has been linked to the development and progression of these diseases, and its modulation has been shown to have therapeutic effects.

Additionally, LYRM7 has been shown to be involved in the regulation of cell signaling pathways that are important for cancer progression. Its dysfunction has been linked to the development and progression of various types of cancer, including breast, lung, and ovarian cancer.

Conclusion

LYRM7 is a non-coding RNA molecule that has been identified in various cellular processes. Its unique structure and various functions make it an attractive target for researchers to explore. The potential drug targets for LYRM7 are numerous and varied, including its role in cell signaling, stem cell biology, and neurodegenerative diseases. Additionally, LYRM7 has also been shown to be involved in various cellular processes that are important for human development and survival, making it an attractive target for biomarkers. Further research is needed to fully understand the role of LYRM7 in these processes and its potential as a drug target.

Protein Name: LYR Motif Containing 7

Functions: Assembly factor required for Rieske Fe-S protein UQCRFS1 incorporation into the cytochrome b-c1 (CIII) complex. Functions as a chaperone, binding to this subunit within the mitochondrial matrix and stabilizing it prior to its translocation and insertion into the late CIII dimeric intermediate within the mitochondrial inner membrane

More Common Targets